{{Rsnum
|rsid=414965
|Gene=CLPTM1L
|Chromosome=5
|position=1324006
|Orientation=minus
|GMAF=0.3499
|Gene_s=CLPTM1L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 35.7 | 46.4 | 17.9
| HCB | 69.3 | 28.5 | 2.2
| JPT | 76.1 | 23.0 | 0.9
| YRI | 18.4 | 51.0 | 30.6
| ASW | 31.6 | 50.9 | 17.5
| CHB | 69.3 | 28.5 | 2.2
| CHD | 69.7 | 27.5 | 2.8
| GIH | 68.3 | 28.7 | 3.0
| LWK | 34.5 | 49.1 | 16.4
| MEX | 59.6 | 38.6 | 1.8
| MKK | 39.1 | 44.9 | 16.0
| TSI | 34.3 | 55.9 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22213090
|Title=Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population
}}

{{on chip | Illumina Human 1M}}